Tempest Therapeutics (TPST) Net Margin (2015 - 2018)
Tempest Therapeutics' Net Margin was -13701.82% in Q3 2018, up 3024.97 percentage points from -16726.79% a year earlier but down 7719.10 percentage points from the prior quarter.
Powered by 
Analysis
Tempest Therapeutics (TPST) Net Margin (2015 - 2018) Analysis & Trends
On a trailing twelve-month basis, Tempest Therapeutics' Net Margin was -19991.16% through Sep 30, 2018, up 98.66 percentage points year-over-year; for FY2017, it came in at -17279.66%, down 4682.42 percentage points from FY2016.
- In earlier years, Net Margin was -12597.24% in FY2016 (+13835.61 pp) and -26432.85% in FY2015.
- Quarterly Net Margin has moved between -114706.67% (Q1 2015) and -5982.72% (Q2 2018) over five years.
- Compared with a year earlier, Net Margin has increased for three straight quarters, with an average year-over-year change of -3087.61 percentage points over the last eight quarters.
- The best year-over-year quarter for Net Margin over five years was Q1 2016 (a gain of 99803.93 percentage points); the worst was Q4 2017 (a drop of 27584.58 percentage points).
- Per Business Quant data, TPST's Net Margin in the three quarters before Q3 2018 was -5982.72% (Q2 2018), -6359.70% (Q1 2018) and -46297.80% (Q4 2017).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 32.99% |
| 10 | Tempest Therapeutics | 4.09 Mn | -26.23 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | -13,701.82% |
| Jun 30, 2018 | -5,982.72% |
| Mar 31, 2018 | -6,359.70% |
| Dec 31, 2017 | -46,297.80% |
| Sep 30, 2017 | -16,726.79% |
| Jun 30, 2017 | -21,650.00% |
| Mar 31, 2017 | -23,642.86% |
| Dec 31, 2016 | -18,713.22% |
| Sep 30, 2016 | -9,792.39% |
| Jun 30, 2016 | -9,824.34% |
| Mar 31, 2016 | -14,902.74% |
| Dec 31, 2015 | -13,121.66% |
| Sep 30, 2015 | -23,896.00% |
| Jun 30, 2015 | -58,300.00% |
| Mar 31, 2015 | -114,706.67% |
API Access
Tempest Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=TPST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "TPST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=TPST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();